A report by ResearchAndMarkets predicts growth in the UK’s private GP Electronic Health Records (EHR) market from 2023-2028 due to the increasing demand for private medical services and technological progress in the healthcare sector. This growth, however, could be hindered by cybersecurity concerns and technical issues.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
